Dr. Frederick Lundry Locke M.D.
Hematologist-Oncologist | Hematology & Oncology
12902 USF MAGNOLIA DR TAMPA FL, 33612About
Dr. Frederick Locke is a hematologist oncologist practicing in Chicago, IL. Dr. Locke specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.
- A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation.
- Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.
- Immunotherapy strategies for multiple myeloma: the present and the future.
- Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
- Merkel cell carcinoma and immunosuppression: what we still need to know.
- Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
- Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.
- An update on current and prospective immunotherapies for chronic lymphocytic leukemia.
- Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.
- Recurrent Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma Presenting as a Breast Implant-Associated Lesion.
- Boosting humoral and cellular immunity to pneumococcus by vaccination before and just after autologous transplant for myeloma.
- IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation.
- Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap.
- Highlights in Aggressive Non-Hodgkin Lymphoma From the 2017 American Society of Clinical Oncology Annual Meeting: Commentary.
Clinical Trials
- Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
- A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
- Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
- Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT)
- Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
- Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease
- A Study Evaluating the Efficacy of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Dr. Frederick Lundry Locke M.D.'s Practice location
Dr. Frederick Lundry Locke M.D.'s reviews
Write ReviewPatient Experience with Dr. Locke
Recommended Articles
- AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Schools Join the Fight Against Lymphoma and Blood Cancers
Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...
- Exercise Proven to Help Lymphoma Patients
People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...
- Teen Treated for Lymphoma to Play College Baseball
Whether it’s the Dodgers or the Red Sox or the local high school team, they’re called ‘the boys of summer’.While summer is when the teams begin competitive play, they are very much the boys of spring as well.The temperature might be cool, but the air is sweet with promise.The players pull...
- John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society
Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...
Nearby Providers
- Dr. Jason Brayer MD, PHD12902 USF Magnolia Drive Tampa Florida 33612
- Dr. Stephen Patterson MD12902 Usf Magnolia Dr Tampa FL 33612
- Onyee Chan M.D.12902 Usf Magnolia Dr Tampa FL 33612
- Dr. Pamela Munster MD12902 Usf Magnolia Dr Tampa FL 33612
- Dr. Andrew Brohl M.D.12902 USF MAGNOLIA DR TAMPA FL 33612
- Dr. Rachid C Baz MD12902 USF MAGNOLIA DR TAMPA FL 33612